SLICC衰弱指数外部验证:预测系统性红斑狼疮不良健康结局
本研究在183例病程较长的系统性红斑狼疮(SLE)患者中外部验证SLICC衰弱指数(SLICC-FI)。基线SLICC-FI每增加0.05,调整混杂后死亡风险增加(HR 1.31,95%CI 1.01-1.70),器官损害累积速率亦增加(IRR 1.18,95%CI 1.07-1.29)。提示SLICC-FI可预测已确诊SLE患者的器官损害累积与死亡风险。
要点
- 基线SLICC-FI每增加0.05与死亡风险增加相关(HR 1.31)。
- 基线SLICC-FI每增加0.05与器官损害累积速率增加相关(IRR 1.18)。
- 基线时29.5%患者被归类为衰弱(SLICC-FI >0.21)。
核心结论
- SLICC-FI测量的衰弱可预测已确诊SLE患者的器官损害累积和死亡风险。
研究设计与样本
- 单中心前瞻性队列的二次分析,纳入183例成人已确诊SLE患者(入组时病程>15个月)。
- 基线为首次同时具备SLICC/ACR损害指数(SDI)和36项短表数据的访视,计算基线SLICC-FI评分。
- 采用Cox回归估计基线SLICC-FI与死亡风险的关联,负二项回归估计与随访期间SDI评分变化率的关联。
主要发现
- 183例患者中女性占89%,平均年龄45.2岁(s.d. 13.2),基线中位病程12.4年(IQR 7.8-17.4)。
- 基线平均SLICC-FI评分为0.17(s.d. 0.09),54例(29.5%)被归类为衰弱(SLICC-FI >0.21)。
- 调整年龄、性别、教育、SLE用药、病程、吸烟状态和基线SDI后,基线SLICC-FI每增加0.05与死亡风险增加相关(HR 1.31,95%CI 1.01-1.70)。
- 调整潜在混杂因素后,基线SLICC-FI每增加0.05与随访期间损害累积增加相关(IRR 1.18,95%CI 1.07-1.29)。
临床怎么用
- 在已确诊SLE患者中可计算基线SLICC-FI以识别衰弱个体,辅助评估死亡和器官损害累积风险。
局限性
- 单中心前瞻性队列的二次分析,样本量183例,外部推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The SLICC frailty index (SLICC-FI) was recently developed as a measure of susceptibility to adverse outcomes in SLE. We aimed to externally validate the SLICC-FI in a prevalent cohort of individuals with more long-standing SLE. METHODS: This secondary analysis included data from a single-centre prospective cohort of adult patients with established SLE (disease duration >15 months at enrolment). The baseline visit was the first at which both SLICC/ACR Damage Index (SDI) and 36-item Short Form data were available. Baseline SLICC-FI scores were calculated. Cox regression models estimated the association between baseline SLICC-FI values and mortality risk. Negative binomial regression models estimated the association of baseline SLICC-FI scores with the rate of change in SDI scores during follow-up. RESULTS: The 183 eligible SLE patients were mostly female (89%) with a mean age of 45.2 years (s.d. 13.2) and a median disease duration of 12.4 years (interquartile range 7.8-17.4) at baseline. The mean baseline SLICC-FI score was 0.17 (s.d. 0.09), with 54 patients (29.5%) classified as frail (SLICC-FI >0.21). Higher baseline SLICC-FI values (per 0.05 increase) were associated with an increased mortality risk [hazard ratio 1.31 (95% CI 1.01, 1.70)] after adjusting for age, sex, education, SLE medication use, disease duration, smoking status and baseline SDI. Higher baseline SLICC-FI values (per 0.05 increase) were associated with increased damage accrual over time [incidence rate ratio 1.18 (95% CI 1.07, 1.29)] after adjusting for potential confounders. CONCLUSION: Frailty, measured using the SLICC-FI, predicts organ damage accrual and mortality risk among individuals with established SLE.
引用
- Legge A, Malone A, Hanly JG, et al. External validation of the Systemic Lupus International Collaborating Clinics Frailty Index as a predictor of adverse health outcomes in systemic lupus erythematosus. Rheumatology (Oxford). 2022. PMID: 34410347. doi:10.1093/rheumatology/keab546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。